Stereotaxis Inc (STXS)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $85.02M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 27.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 34.2, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about STXS
News
STXS Valuation
GNG's valuation label for STXS is Undervalued. It trades at 19.6x forward earnings.
- Forward P/E
- 19.6x
- P/FCF
- -5.3x
- P/B
- 3.9x
STXS Profitability: Margins, ROIC and FCF
Stereotaxis (STXS) has a gross margin of 52.5%, an operating margin of -65.0% and a net margin of -70.9%. It posts -62.4% ROIC and a -49.2% FCF margin.
- Gross margin
- 52.5%
- Operating margin
- -65.0%
- Net margin
- -70.9%
- ROIC
- -62.4%
- ROE
- -117.4%
- FCF margin
- -49.2%
- FCF yield
- -18.8%
Stereotaxis Competitors
The companies most similar to Stereotaxis (STXS) include KORU Medical Systems, Daxor and Anbio Biotechnology Class A Ordinary Shares.
Sector: Healthcare
Companies most similar to StereotaxisSTXS Analyst Ratings
Stereotaxis (STXS) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
STXS Bull Case vs Bear Case
Bull case
- STXS grew quarterly revenue 19.6% year over year.
Bear case
- STXS has a -70.9% net profit margin.
- STXS beat EPS estimates in 12.5% of its last 8 reported quarters.
STXS Earnings: Beat Rate and Next Report
Stereotaxis (STXS) beat the EPS estimate in 1 of the last 8 quarters (12.5%). Its next report is expected on Mar 8, 2027.
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -17.9%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.05
STXS Earnings Date
STXS reports Mar 8, 2027. The date is estimated.
STXS Earnings Call
The latest STXS earnings call transcript on file is labeled 2026Q1.
Read the 2026Q1 transcriptSTXS ETF Holders
GNG tracks 4 ETFs that hold STXS. The largest weights:
- iShares Russell 2000 ETF (IWM), 0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About STXS
When does STXS report earnings?
Stereotaxis Inc (STXS) is expected to report earnings on Mar 8, 2027.
Does STXS pay dividends?
Stereotaxis Inc (STXS) does not currently pay a regular dividend.
What is STXS's market cap?
Stereotaxis Inc (STXS) has a market capitalization of $85.02M with a current stock price of $0.81.
STXS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.